论文部分内容阅读
目的:重点探索在复发转移乳腺癌患者中采用多西他赛和卡培他滨进行治疗的效果。方法:选取的研究对象是2011年1月初至2013年12月底在我院接受治疗的42例复发转移乳腺癌患者,将患者随机分成两组,采用多西他赛治疗21例对照组患者,同时采用多西他赛和卡培他滨治疗21例观察组患者,对比两种治疗方案的疗效。结果:对照组的治疗效果较差,优良率仅仅达到76.19%。观察组的治疗效果较好,优良率高达95.24%,观察组的优良率显著高于对照组。对照组不良反应发生率高达28.57%,观察组不良反应发生率为4.76%。观察组的不良反应显著少于对照组,结论:在复发转移乳腺癌患者中采用多西他赛和卡培他滨进行治疗的效果较好,安全性较高,值得推荐。
Objective: To explore the effect of docetaxel and capecitabine in the treatment of recurrent breast cancer. Methods: Forty-two patients with recurrent breast cancer who were treated in our hospital from the beginning of January 2011 to the end of December 2013 were selected and randomly divided into two groups. 21 patients in the control group were treated with docetaxel 21 patients in the observation group were treated with docetaxel and capecitabine, and the efficacy of the two treatment regimens was compared. Results: The treatment effect of the control group was poor, the excellent and good rate was only 76.19%. Observation group’s treatment effect is good, excellent and good rate as high as 95.24%, the observation group’s excellent rate was significantly higher than the control group. The incidence of adverse reactions in the control group was as high as 28.57%, and the incidence of adverse reactions in the observation group was 4.76%. Adverse reactions in the observation group were significantly less than those in the control group. Conclusion: Docetaxel and capecitabine are more effective and safe in relapse-metastatic breast cancer patients, which is worth recommending.